Morgan Stanley’s Iterum Therapeutics ITRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.33K Buy
9,373
+2,900
+45% +$2.89K ﹤0.01% 6872
2025
Q1
$7.96K Sell
6,473
-5,256
-45% -$6.47K ﹤0.01% 6871
2024
Q4
$20.8K Buy
11,729
+6,250
+114% +$11.1K ﹤0.01% 6562
2024
Q3
$5.97K Hold
5,479
﹤0.01% 6857
2024
Q2
$6.27K Hold
5,479
﹤0.01% 6797
2024
Q1
$8.44K Sell
5,479
-5,479
-50% -$8.44K ﹤0.01% 6761
2023
Q4
$21.6K Sell
10,958
-2,992
-21% -$5.89K ﹤0.01% 6635
2023
Q3
$11.2K Hold
13,950
﹤0.01% 6695
2023
Q2
$14.9K Hold
13,950
﹤0.01% 6662
2023
Q1
$13.9K Buy
13,950
+5,460
+64% +$5.46K ﹤0.01% 6755
2022
Q4
$7.13K Sell
8,490
-1,157
-12% -$972 ﹤0.01% 7050
2022
Q3
$16K Sell
9,647
-5,100
-35% -$8.46K ﹤0.01% 6887
2022
Q2
$44K Sell
14,747
-335
-2% -$1K ﹤0.01% 6671
2022
Q1
$81K Buy
15,082
+2,101
+16% +$11.3K ﹤0.01% 6453
2021
Q4
$76K Sell
12,981
-17,446
-57% -$102K ﹤0.01% 6593
2021
Q3
$255K Buy
30,427
+26,625
+700% +$223K ﹤0.01% 5871
2021
Q2
$131K Sell
3,802
-1,164
-23% -$40.1K ﹤0.01% 6222
2021
Q1
$105K Buy
4,966
+3,885
+359% +$82.1K ﹤0.01% 5980
2020
Q4
$16K Buy
+1,081
New +$16K ﹤0.01% 6500
2020
Q3
Sell
-6
Closed 6782
2020
Q2
$0 Sell
6
-318
-98% ﹤0.01% 6659
2020
Q1
$13K Buy
324
+200
+161% +$8.03K ﹤0.01% 5955
2019
Q4
$8K Buy
124
+123
+12,300% +$7.94K ﹤0.01% 6314
2019
Q3
$0 Sell
1
-1
-50% ﹤0.01% 6690
2019
Q2
$0 Sell
2
-49
-96% ﹤0.01% 6690
2019
Q1
$6K Sell
51
-67
-57% -$7.88K ﹤0.01% 6292
2018
Q4
$9K Sell
118
-55
-32% -$4.2K ﹤0.01% 6186
2018
Q3
$17K Buy
173
+113
+188% +$11.1K ﹤0.01% 6184
2018
Q2
$10K Buy
+60
New +$10K ﹤0.01% 6307